Similar articles

• Blood component therapy in the perinatal period: guidelines and recommendations.

  DePalma L, Luban NL. DePalma L, et al. Semin Perinatol. 1990 Oct;14(5):403-15. Semin Perinatol. 1990. PMID: 2126893 Review. No abstract available.
• Optimal use of blood components and derivatives.

  Walter WJ, Oberman HA. Walter WJ, et al. Otolaryngol Clin North Am. 1981 Aug;14(3):739-53. Otolaryngol Clin North Am. 1981. PMID: 6795570 Review. No abstract available.
• Blood component therapy in neonatal medicine.

  Lenes BA, Sacher RA. Lenes BA, et al. Clin Lab Med. 1981 Jun;1(2):285-309. Clin Lab Med. 1981. PMID: 6809397 Review. No abstract available.
• Blood products.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1979 Nov 16;21(23):93-6. Med Lett Drugs Ther. 1979. PMID: 502967 No abstract available.
• Current transfusion practices.

  Pierce LE, Beall CL. Pierce LE, et al. Am Fam Physician. 1975 Mar;11(3):129-36. Am Fam Physician. 1975. PMID: 1114933